Will stem cell-based treatments make a difference to the developing world?September 12, 2006A new study in the open access journal PLoS Medicine suggests that developing countries could benefit enormously from the new field of regenerative medicine, in which treatments are being developed from stem cells. Developing countries are increasingly struggling to manage epidemic rates of chronic diseases, like diabetes, stroke, and heart disease, and it is expected that stem cell research could lead to better treatments for such chronic conditions. In the study, by Abdallah Daar (McLaughlin Centre for Molecular Medicine, University of Toronto) and colleagues, an international panel of 44 experts ranked the ten most promising applications of regenerative medicine for improving health in developing countries. The experts included researchers in disciplines contributing to regenerative medicine and clinicians working in fields that will be at the forefront of applying regenerative medicine therapies.
The top-ranked application was novel methods of insulin replacement and pancreatic islet cell regeneration for diabetes. The panelists ranked this number one because of the high prevalence of diabetes in developing countries and the major health, social, and economic burden that results. Panelists emphasized that controlling diabetes would in turn reduce the incidence of diabetes complications such as blindness, heart disease, chronic kidney disease, and diabetic ulcers. The panelists noted that repeated insulin treatments are costly and inaccessible to many patients in developing countries. They felt that regenerative medicine therapies, such as bone marrow stem cell transplantation or microencapsulated islet cells using new biomaterials, could provide a permanent solution to treating diabetes and reduce the financial burden caused by the purchase of insulin. The second-ranked application was regenerating failed heart muscle using the patient's own cells, injected directly or introduced via patches, for treating heart muscle damage due to a heart attack or a cardiomyopathy (a condition causing weakness of the heart muscle). Panelists noted that such therapy shows promising early results, and is being tested in clinical trials in a number of countries. Other highly ranked applications were immune system enhancement by engineered immune cells, new vaccination strategies for treating infectious diseases, new stem cell-based technologies for replacing skin loss due to burns, wounds, and diabetic ulcers, and new blood substitutes. The study results, say the authors, "may be used as a guide for the policy formulation of international and bilateral aid agencies, and by developing countries to help target policy aimed at initiating or developing further their existing capacity in regenerative medicine." Public Library of Science | |||||||||||||||||||||
|
Related Stem Cell Current Events and Stem Cell News Articles Mayo researchers explore issues related to multiple myeloma treatment Multiple myeloma (MM) is a cancer of plasma cells that affects approximately 3 in 100,000 people each year. Although there is no cure for this disease, researchers have developed treatments that help relieve pain, control complications, and slow the progress of MM in many patients. Emerging model organisms featured in CSH Protocols Biological research has long relied on a small number of model organisms, species chosen because they are amenable to laboratory research and suitable for the study of a range of biological problems. Reversible 3-D cell culture gel invented Singapore's Institute of Bioengineering and Nanotechnology (IBN), which celebrates its fifth anniversary this year, has invented a unique user-friendly gel that can liquefy on demand, with the potential to revolutionize three-dimensional (3D) cell culture for medical research. What to do with leftover embryos in fertility clinics? The majority of infertility patients are in favor of using left-over embryos for stem cell research and would also support selling left-over embryos to other couples, according to a recent survey. Pittsburgh researchers identify source of multipotent stem cells with broad regenerative potential In a promising finding for the field of regenerative medicine, stem cell researchers at Children's Hospital of Pittsburgh of UPMC have identified a source of adult stem cells found on the walls of blood vessels with the unlimited potential to differentiate into human tissues such as bone, cartilage and muscle. Stem cells may solve mystery of early pregnancy breast cancer protection The answer to why an early pregnancy seems to protect against breast cancer could rest with a decrease in stem cells found after animals have given birth, said researchers at Baylor College of Medicine in a report that appears in the current issue of the journal Stem Cell. Scientists identify genes capable of regulating stem cell function Scientists from The Forsyth Institute, Boston, MA, and the Howard Hughes Medical Institute at the University of Utah School of Medicine have developed a new system in which to study known mammalian adult stem cell disorders. Embryonic stem cells might help reduce transplantation rejection Researchers have shown that immune-defense cells influenced by embryonic stem cell-derived cells can help prevent the rejection of hearts transplanted into mice, all without the use of immunosuppressive drugs. Stem cell regeneration repairs congenital heart defect Mayo Clinic investigators have demonstrated that stem cells can be used to regenerate heart tissue to treat dilated cardiomyopathy, a congenital defect. OU Cancer Institute Scientists Identify New Cancer Stem Cell Marker; Developing Drug to Stop Cancer Recurrence After years of working toward this goal, scientists at the OU Cancer Institute have found a way to isolate cancer stem cells in tumors so they can target the cells and kill them, keeping cancer from returning. More Stem Cell Current Events and Stem Cell News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||